Navigation Links
Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
Date:9/9/2009

CLEVELAND, Ohio and DENVER, Colorado, September 9 /PRNewswire/ -- Simbionix USA Corporation, a global leader in simulation and training products for clinical professionals, today announced the appointment of Mr. Paul Jensen as the new General Manager for Simbionix's eLearning and Content business.

Mr. Jensen is an information services executive with extensive experience in building innovative information products and services for a variety of professional markets including education and corporate training. He was responsible for the learning management system for Aplia, a leading Web-based homework solution for higher education, and he created the first eLearning product strategy for Thomson Learning. Most recently, Mr. Jensen held several senior management roles with Wolters Kluwer, a global leader in information services and publishing, including responsibility for enterprise-wide strategies and business priorities for online content delivery systems. He earned his MBA, with honors, from Columbia Business School.

"Over the previous four months we were involved in an intensive, nationwide recruitment process to find the ideal person to lead our growing eLearning and Content business, and we are very pleased to have Paul join Simbionix," said Gary Zamler, Simbionix's CEO. "In order to meet the growing training and performance improvement needs of our global customers, Simbionix now offers a full range of integrated training solutions including virtual reality simulations, online courseware and learning management systems under our MentorLearn(TM) umbrella of products and services. Paul's talent, proven leadership, experience in identifying global trends and commercializing new e-Learning products and services, as well as in the delivery of online content, will be another building block in Simbionix's exponential growth and success in these areas of the global training and performance improvement market."

About Simbionix USA Corporation

Simbionix is the leader in the development and delivery of innovative and effective virtual reality simulation products and solutions for clinical education and training of medical professionals. The products are designed to accelerate best-practice medical training, advance clinical performance, and improve patient safety.

The Simbionix product line includes the ANGIO Mentor(TM) line for endovascular procedures, LAP Mentor(TM) line for laparoscopic surgical procedures, GI Mentor(TM) for upper and lower gastrointestinal procedures and the URO Mentor(TM) for urological procedures. In addition, Simbionix distributes the HystSim(TM) for hysteroscopic procedures. Each simulation platform is a leading simulator in the relevant clinical area.

Simbionix simulation products have been validated in several scientific studies and the company cooperates closely with both industry and leading medical institutions to develop the most advanced simulators for the training and assessment of medical professionals.

    Contact:
    Gary Zamler
    CEO
    Simbionix
    Tel: +1-216-229-2040
    gary@simbionix.com



'/>"/>
SOURCE Simbionix
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
2. Simbionix Increases Product Offerings for OB/GYN Physicians
3. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
4. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
5. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
6. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
7. Simbionix Launches Innovative Patient-Specific Simulation
8. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
9. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
10. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
11. eBioscience Corporation Acquires NatuTec GmbH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:10/4/2017)... BLOOMINGTON, Ill. , Oct. 4, 2017  GCE Solutions, a ... powerful new data and document anonymization solution on October 4, 2017. ... the pharmaceutical field to comply with policy 0070 of the European ... documents and data. ... Innovation by GCE Solutions ...
(Date:7/20/2017)... Delta (NYSE: DAL ) customers now can use fingerprints instead ... National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan Washington National Airport ... Delta,s biometric boarding pass experience that launched in ... the boarding process to allow eligible Delta SkyMiles Members who are enrolled ...
(Date:6/14/2017)... 15, 2017  IBM (NYSE: IBM ) is introducing several ... dedicated to developing collaboration between startups and global businesses, taking ... During the event, nine startups will showcase the solutions they ... industries. France is ... with a 30 percent increase in the number of startups ...
Breaking Biology News(10 mins):